Financial Summary -
Embryom Capital Investment Srl
Unique identification code:29900760
Registration number:J30/177/2012
Nace:1051
Sales - Ron
676.323
Net Profit - Ron
86.295
Employees
10
Open Account
Company Embryom Capital Investment Srl with Fiscal Code 29900760
recorded a turnover of 2024 of
676.323,
with a net profit of
86.295
and having an average number of employees of
10.
The company operates in the field of Fabricarea produselor lactate şi a brânzeturilor having the NACE code 1051.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Embryom Capital Investment Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
42.364
210.129
217.489
291.545
355.969
424.136
496.251
573.497
682.823
676.323
Total Income - EUR
42.371
217.944
221.764
296.227
390.214
433.410
500.668
592.294
853.808
693.558
Total Expenses - EUR
41.038
213.147
219.461
268.508
310.551
379.446
416.215
554.009
619.489
594.613
Gross Profit/Loss - EUR
1.333
4.797
2.304
27.719
79.663
53.964
84.453
38.285
234.319
98.946
Net Profit/Loss - EUR
62
2.946
249
24.781
75.790
50.487
79.822
33.533
220.867
86.295
Employees
3
5
9
9
9
9
9
8
9
10
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -0.4%, from 682.823 euro in the year 2023, to 676.323 euro in 2024.
The Net Profit decreased by -133.337 euro, from 220.867 euro in 2023, to 86.295 in the last year.
Check the financial reports for the company - Embryom Capital Investment Srl
Financial Rating - EMBRYOM CAPITAL INVESTMENT SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Embryom Capital Investment Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Embryom Capital Investment Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Embryom Capital Investment Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Embryom Capital Investment Srl - CUI 29900760
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
83.218
139.420
138.926
135.369
176.491
169.922
234.020
251.279
236.411
323.519
Current Assets
31.128
19.754
19.058
28.507
49.473
58.424
69.129
102.721
300.044
350.132
Inventories
8.547
8.169
12.721
15.997
17.329
22.233
26.115
26.712
27.908
26.769
Receivables
12.749
10.323
6.083
10.285
14.254
16.053
19.381
29.126
21.967
33.057
Cash
9.831
1.261
254
2.225
17.890
20.137
23.632
46.883
250.169
290.306
Shareholders Funds
824
3.762
3.947
28.656
128.544
124.491
152.611
186.617
406.918
490.939
Social Capital
135
134
131
129
126
248
243
243
243
241
Debts
113.522
155.412
154.038
135.220
97.420
103.854
146.206
163.167
129.537
181.354
Income in Advance
0
0
0
0
0
0
4.332
4.215
0
1.357
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"1051 - 1051"
CAEN Financial Year
1051
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
350.132 euro in 2024 which includes Inventories of
26.769 euro, Receivables of
33.057 euro and cash availability of
290.306 euro.
The company's Equity was valued at
490.939 euro, while total Liabilities amounted to
181.354 euro.
Equity increased by 86.296 euro, from 406.918 euro in 2023, to 490.939 in 2024.
The Debt Ratio was 26.9% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Embryom Capital Investment Srl